---
title: "Modular workflow for biomedical entity normalization across heterogeneous ontologies"
id: "biorxiv-2-a-modular-workflow-for-biomedical-entity-normalization-across-heterogeneous"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-2-a-modular-workflow-for-biomedical-entity-normalization-across-heterogeneous"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.17.767229v1?rss=1"
published_at: "2026-11-19T10:09:07.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Modular workflow for biomedical entity normalization across heterogeneous ontologies
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-2-a-modular-workflow-for-biomedical-entity-normalization-across-heterogeneous
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.17.767229v1?rss=1)
- **Published At:** 2026-11-19T10:09:07.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The authors developed a modular named-entity normalization (NEN) workflow to map biomedical mentions to ontology terms across heterogeneous resources. The workflow combines exact matching, lexical and semantic candidate retrieval, and a reranking stage. - Candidate retrieval integrates multiple methods: **BM25**, fuzzy matching, character n-gram similarity, and **SapBERT**; the workflow does not require ontology-specific training. - Evaluation was performed across four ontologies: **Human Phenotype Ontology** (HPO), **Cell Ontology** (CL), **Uberon**, and **Gene Ontology** (GO), using multiple benchmarks. - The study assessed retrieval recall, reranking accuracy, and end-to-end normalization accuracy separately, enabling analysis of where failures occur. - Retrieval performance varied by ontology and benchmark; lexical and semantic retrieval methods provided complementary candidate coverage in some settings. - Increasing candidate-set size raised retrieval recall but sometimes reduced overall normalization accuracy because larger candidate pools could impair reranker performance. - Retrieval difficulty correlated with mention characteristics and ontology categories, according to the authors' analysis. - The workflow was compared with a specialized cell-type system, CellExLink; the source reported this comparison but did not provide full comparative metrics in the abstract. - The authors provide code and materials at a public repository (link in footnotes) to support reproducibility and further evaluation.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=lEqe3XxNBUWCe788LQ4uIPc9O8OQ7Otyc_FbCS9D7V0-1795082987.178053-1.2.1.1-Ndjkuo_2wR0GxnnPA2WKoEHUe9qwNg4nRsnzZNmXGdbrnhPsTj1XQr.CE4iKP.sz) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.17.767229v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.17.767229v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # A modular workflow for biomedical entity normalization across heterogeneous biological ontologies Ana Amil, [ View ORCID Profile](http://orcid.org/0000-0001-6911-1591)Monica Chagoyen doi: https://doi.org/10.64898/2026.11.17.767229 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Ana Amil Cajal Neuroscience Center (CNC-CSIC) * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ana%2BAmil%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Amil%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AAna%2BAmil%2B) Monica Chagoyen Cajal Neuroscience Center (CNC-CSIC) * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Monica%2BChagoyen%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Chagoyen%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMonica%2BChagoyen%2B) * [ORCID record for Monica Chagoyen](http://orcid.org/0000-0001-6911-1591 "Open in new tab") * For correspondence: monica.chagoyen@csic.es * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.17.767229v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5976288/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.17.767229v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5976288/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.17.767229v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5976288/1) * [Supplementary material](https://www.biorxiv.org/content/10.64898/2026.11.17.767229v1.supplementary-material)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_data/node:5976288/1) * [Data/Code](https://www.biorxiv.org/content/10.64898/2026.11.17.767229v1.external-links)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_data_code/node:5976288/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.17.767229v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5976288/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Understanding the biological mechanisms underlying rare diseases requires integrating information about phenotypes, cell types, anatomical structures, and molecular functions and processes. Although some of this knowledge is available in structured resources, additional relationships remain dispersed across biomedical literature. Extracting and integrating this information requires normalizing heterogeneous biological entities against specialized ontologies. This motivated the development of a common biomedical named entity normalization (NEN) workflow and the evaluation of its performance across different entity types and ontologies. We developed a modular NEN workflow combining exact matching, lexical and semantic candidate retrieval, and reranking, without requiring ontology-specific training. Candidate retrieval integrates BM25, fuzzy matching, character n-gram similarity, and SapBERT. We evaluated the workflow across the Human Phenotype Ontology (HPO), Cell Ontology (CL), Uberon, and Gene Ontology (GO) using multiple benchmarks, separately assessing candidate retrieval, reranking accuracy, and overall normalization accuracy. We also investigated factors associated with retrieval difficulty and compared the workflow with CellExLink, a specialized cell-type normalization system. Retrieval performance varied across ontologies and benchmarks, with lexical and semantic methods providing complementary candidate coverage in some settings. Increasing candidate-set size improved retrieval recall but did not necessarily improve overall normalization accuracy, as larger candidate sets could reduce reranking performance. Retrieval difficulty was associated with mention characteristics and ontology categories. Our evaluation identifies the performance characteristics and limitations of a common normalization workflow across heterogeneous biological ontologies, highlighting the importance of assessing candidate retrieval and selection separately. The workflow provides a methodological foundation for extracting and integrating biological information from rare disease literature, with potential applicability to other biomedical information-extraction tasks requiring normalization against these ontologies. ### Competing Interest Statement The authors have declared no competing interest. ## Footnotes * ## Funder Information Declared Fundacion Isabel Gemio, Madrid, ES Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC 4.0 International license](http://creativecommons.org/licenses/by-nc/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.17.767229v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.11.17.767357v1 "Dissociable patterns of neurophysiological alterations during guided search in schizophrenia and autism: Evidence from fixation-related potentials, alpha modulation, and functional MRI.")[Next ](https://www.biorxiv.org/content/10.64898/2026.11.17.767343v1 "Novel selective CDK4-inhibitor ALK-13743: Functional determinants of response in ER+ breast cancer models") Posted November 19, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.17.767229v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/19/2026.11.17.767229.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [Supplementary Material ](https://www.biorxiv.org/content/10.64898/2026.11.17.767229v1.supplementary-material) [ Data/Code](https://www.biorxiv.org/content/early/2026/11/19/2026.11.17.767229.external-links) [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) A modular workflow for biomedical entity normalization across heterogeneous biological ontologies Ana Amil, Monica Chagoyen bioRxiv 2026.11.17.767229; doi: https://doi.org/10.64898/2026.11.17.767229 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.17.767229v1%26text%3DA%2520modular%2520workflow%2520for%2520biomedical%2520entity%2520normalization%2520across%2520heterogeneous%2520biological%2520ontologies "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.17.767229v1%26t%3DA%2520modular%2520workflow%2520for%2520biomedical%2520entity%2520normalization%2520across%2520heterogeneous%2520biological%2520ontologies "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.17.767229v1%26title%3DA%2520modular%2520workflow%2520for%2520biomedical%2520entity%2520normalization%2520across%2520heterogeneous%2520biological%2520ontologies%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.17.767229v1%26title%3DA%2520modular%2520workflow%2520for%2520biomedical%2520entity%2520normalization%2520across%2520heterogeneous%2520biological%2520ontologies "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.11.17.767229) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.64898/2026.11.17.767229v1&count=horizontal&via=&text=A%20modular%20workflow%20for%20biomedical%20entity%20normalization%20across%20heterogeneous%20biological%20ontologies&counturl=www.biorxiv.org/content/10.64898/2026.11.17.767229v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.biorxiv.org/collection/animal-behavior-and-cognition) (8164) * [Biochemistry](https://www.biorxiv.org/collection/biochemistry) (19027) * [Bioengineering](https://www.biorxiv.org/collection/bioengineering) (15171) * [Bioinformatics](https://www.biorxiv.org/collection/bioinformatics) (46124) * [Biophysics](https://www.biorxiv.org/collection/biophysics) (22958) * [Cancer Biology](https://www.biorxiv.org/collection/cancer-biology) (20359) * [Cell Biology](https://www.biorxiv.org/collection/cell-biology) (27642) * [Clinical Trials](https://www.biorxiv.org/collection/clinical-trials) (138) * [Developmental Biology](https://www.biorxiv.org/collection/developmental-biology) (14289) * [Ecology](https://www.biorxiv.org/collection/ecology) (21638) * [Epidemiology](https://www.biorxiv.org/collection/epidemiology) (2067) * [Evolutionary Biology](https://www.biorxiv.org/collection/evolutionary-biology) (26047) * [Genetics](https://www.biorxiv.org/collection/genetics) (16491) * [Genomics](https://www.biorxiv.org/collection/genomics) (24115) * [Immunology](https://www.biorxiv.org/collection/immunology) (19278) * [Microbiology](https://www.biorxiv.org/collection/microbiology) (43722) * [Molecular Biology](https://www.biorxiv.org/collection/molecular-biology) (18592) * [Neuroscience](https://www.biorxiv.org/collection/neuroscience) (96326) * [Paleontology](https://www.bi
## Related Clinical Research

- [Platelet-programmed circulating tumor cells engage monocytes via a candidate CD40LG–ITGA5:ITGB1 my](https://medichelpline.com/clinical-feed/biorxiv-7-platelet-programmed-circulating-tumor-cells-signal-to-monocytes-through-a.md)
- [Retinal changes on OCT may predict atrial fibrillation risk years earlier](https://medichelpline.com/clinical-feed/medical-news-today-0-how-changes-in-the-eyes-may-help-spot-afib-risk-years-early.md)
- [REMI: Free tool enabling truncated proximity searches in PubMed](https://medichelpline.com/clinical-feed/medrxiv-23-remi-a-free-tool-for-truncated-proximity-searching-in-pubmed.md)
- [Creatine for Healthy Aging: Examining a Decade of Use](https://medichelpline.com/clinical-feed/medical-news-today-0-age-appropriate-i-ve-taken-creatine-for-10-years-does-it-help-healthy-aging.md)
- [Chemosensory System Evolution in Actinomycetota: Polyphyly and Lineage-Specific Expansion](https://medichelpline.com/clinical-feed/biorxiv-5-polyphyletic-origins-and-lineage-specific-expansion-of-chemosensory-systems-in.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.